BioNTech SE

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators. 

CEO
Ugur Sahin
CEOUgur Sahin
Employees
7,807
Employees7,807
Headquarters
Mainz, Rheinland-Pfalz
HeadquartersMainz, Rheinland-Pfalz
Founded
2008
Founded2008
Employees
7,807
Employees7,807

BNTX Key Statistics

Market cap
22.93B
Market cap22.93B
Price-Earnings ratio
-17.43
Price-Earnings ratio-17.43
Dividend yield
Dividend yield
Average volume
874.03K
Average volume874.03K
High today
$91.43
High today$91.43
Low today
$87.45
Low today$87.45
Open price
$87.67
Open price$87.67
Volume
786.07K
Volume786.07K
52 Week high
$124.00
52 Week high$124.00
52 Week low
$79.52
52 Week low$79.52

Analyst ratings

73%

of 22 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.